Davos and The Trillion Dollar Upside to Longevity

Welcome to today’s special edition of Longr Reads, where we cast our lens on the dynamic intersection of longevity, investment, and global thought leadership as seen at the recent World Economic Forum in Davos.

Longevity science is not only a health matter but also a significant economic and technological concern. We begin by examining the Longevity Investors Lunch at Davos, a crucial event where investors and experts converge to discuss the future of health and rejuvenation. Then, we delve into the economic ramifications of longevity science, exploring the profound impact of aging on global economies and healthcare systems. Lastly, we turn to the innovative realm of sleep health, highlighting the advancement and investment in sleep technology with Onera’s recent success.

Let’s dive in…

Eleanor Garth’s insightful report on the Longevity Investors Lunch, held during the World Economic Forum in Davos, sheds light on the intersection of longevity science and investment.

This event, set amidst the global stage of the WEF, serves as a critical platform where the future of health and wellness is not only discussed but actively shaped. The Longevity Investors Lunch, organized by Maximon and the Longevity Investors Conference, brings together 60 selected high-level investors and key opinion leaders in a setting that encourages not just discourse but potential groundbreaking collaborations.

The event features discussions led by renowned experts like Professor Evelyne Yehudit Bischof and Alex Zhavoronkov, covering a spectrum of topics from brain health to the integration of AI in longevity science.

Garth’s article emphasizes the importance of such gatherings in propelling the longevity industry forward, highlighting Davos as a pivotal meeting point for shaping a future where longevity and health are central to our societal development.

Longevity Technology

“The Trillion Dollar Upside to Longevity,” provides a compelling economic perspective on the burgeoning field of longevity science.

Focusing on a recent study by notable researchers Andrew J. Scott, David Sinclair, and Martin Ellison, the piece articulates the vast economic benefits that could arise from targeting aging rather than individual diseases. This innovative approach, using the Value of Statistical Life (VSL) model, places a monetary value on the gains from extended life expectancy and improved health, presenting a radical shift in how we perceive the economics of aging.

Slowing down the aging process, thus reducing the rate at which biological damage occurs, not only improves health and mortality rates but also offers tremendous economic potential. Evangelou adeptly navigates through complex data, illustrating how a slowdown in aging could be worth trillions of dollars.

This piece challenges conventional healthcare approaches, advocating for a policy pivot towards ‘healthy aging’ and its far-reaching implications on global economies and societies.

Longevity Technology

Paul Sawers’ article about Onera Health’s recent funding success spotlights a critical yet often overlooked aspect of longevity and health: sleep science.

Onera, a Dutch startup specializing in sleep diagnostic and monitoring technology, has raised a significant €30 million ($32 million) in its latest Series C funding round. This investment underscores the increasing recognition of sleep’s vital role in overall health and longevity.

Onera distinguishes itself by offering a clinical-grade solution for sleep studies, capable of being conducted in the comfort of patients’ homes. This ‘polysomnography-as-a-service’ model represents a significant advancement in the field, enabling more accurate and convenient sleep health assessments. Sawers’ report delves into the specifics of Onera’s technology, including its regulatory approvals and future plans for geographic expansion and R&D.

This funding milestone reflects the broader trend of integrating technology into personal health management, a key component in the future of longevity.

TechCrunch

In this edition we’ve journeyed through the landscapes of longevity, investment, and innovation, from the strategic discussions at the World Economic Forum in Davos to the economic analyses and technological advancements in sleep health.

The Longevity Investors Lunch at Davos highlights the importance of strategic investment and collaboration in advancing longevity science. Christos Evangelou’s article offers a novel economic perspective, emphasizing the immense potential of targeting aging over individual diseases. Meanwhile, Onera’s success in securing significant funding for its innovative sleep technology underscores the expanding scope of health and longevity, emphasizing the importance of quality sleep in achieving a healthier, longer life.

Collectively we illustrate a future where longevity is intertwined with technological advancement, economic foresight, and a holistic approach to health and well-being.

Until next time,

The Longr Reads Team

Longr Reads’ of the Week

Advertise with us // Book a call with Longr